Skip to main content

Table 2 Clinical and laboratory features of patients with juvenile idiopathic arthritis at the time of determination of CCL21 in sera and synovial fluid

From: Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+memory T cells homing to the joints in juvenile idiopathic arthritis

Course

No. of patients

Age (years)

Disease duration (years)

No. of joints with active/limited range of motion

PGI

ESR (mm/h)

Treatment; n

Polyarticular

12

11.5 (4.3–14.3)

3.4 (0.5–1.2)

5.3 (1–13)/18.3 (1–22)

7.8 (5–10)

78 (24–137)

NSAID, MTX; 8

       

NSAID, CS, MTX; 2

       

NSAID, CS; 1

       

NSAID alone; 1

Oligoarticular

16

7.5 (2.1–15.9)

2.4 (0.3–14)

1.8 (1–4)/1.9 (1–4)

6.9 (5–10)

31.5 (5–65)

NSAID alone; 11

       

NSAID, MTX; 2

       

Nil; 3

  1. Results are means (ranges in parentheses). See also 'Patients' in the Methods section.
  2. CS, corticosteroids; ESR, erythrocyte sedimentation rate; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drugs; PGI, physician global index.